Market Cap (In GBp)
2.07 Million
Revenue (In GBp)
1953.00
Net Income (In GBp)
-1.26 Million
Avg. Volume
1.02 Million
- Currency
- GBp
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.365-1.5
- PE
- -
- EPS
- -
- Beta Value
- -0.425
- ISIN
- GB00BYW8QM32
- CUSIP
- G6362P106
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Nigel James Theobald
- Employee Count
- -
- Website
- https://www.n4pharma.com
- Ipo Date
- 1988-07-01
- Details
- N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
More Stocks
-
BLACKROSEBlack Rose Industries Limited
BLACKROSE
-
001896
-
002148
-
8198
-
GAHREIT
-
STCK
-
AQUA
-
600644